Navigation Links
Pfizer supports open access publishing for researchers in low-income countries
Date:5/5/2009

Today, Pfizer announced an agreement with BioMed Central to launch an open access waiver fund which will support automatic waivers of publication fees for authors from low-income countries.

Thanks to the open access waiver fund, researchers in low-income countries can publish research articles in BioMed Central's open access journals without the need to pay a publication fee.

Speaking of the agreement Dr Jack Watters, Vice President, Pfizer External Medical Affairs said "Pfizer's support for open access publishing is driven by a recognition of the wide benefits of global access to the latest research results, and the crucial role that open access journals can play in the communication of those results. In addition, we feel that it is critically important that the benefits of scientific publication are extended to all scientists who do quality research, and that providing this access will promote much-needed recognition of research conducted in developing countries.

Matthew Cockerill, BioMed Central's Managing Director, commented: "Researchers working in low-income countries have been strong supporters of open access publishing. Many of BioMed Central's most successful journals such as Malaria Journal and BMC Public Health, focus on issues of strong relevance to developing countries and publish many articles from these countries. BioMed Central's policy of automatic waivers for low-income countries ensures that researchers based in these countries will face no financial barrier to publishing and sharing their work in a way that makes it globally accessible."


'/>"/>

Contact: Matt McKay
matthew.mckay@biomedcentral.com
44-020-319-22216
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. Pfizer inks global license to Genomatix Software and databases
2. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
3. $10 million Simons Foundation gift supports new initiative with Institute for Advanced Study
4. Lancet study supports new, highly effective treatment for blood disorder
5. Research supports toxoplasmosis link to schizophrenia
6. VCU survey: US public supports genetic research, testing and government spending on research
7. Synthetic virus supports a bat origin for SARS
8. The MDS foundation supports vidazas recommendation for European approval
9. The MDS Foundation supports the FDAs decision to expand vidaza label to include survival data
10. New book further supports controversial theory of Man the Hunted
11. Grant supports emerging field of massive data analysis and visual analytics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 21, 2017 Vigilant Solutions , a ... enforcement agencies, announced today the appointment of retired FBI ... public safety business development. Mr. Sheridan brings ... including a focus on the aviation transportation sector, to ... position, Mr. Sheridan served as the Aviation Liaison Agent ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... 22, 2017 , ... Researchers face a fundamental challenge as ... full-size tissues, bones, even whole organs to implant in people to treat disease ... into the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t ...
(Date:3/22/2017)... Mass. , March 22, 2017 Good ... that it has eclipsed the 130 million covered lives ... Blue Shield of Texas . With ... the Company continues to enjoy strong payor acceptance based ... its clinical programs and genetic counseling, its industry-leading customer ...
(Date:3/22/2017)... , March 22, 2017 ... fragmented, states a research report by Transparency Market Research ... Inc., Amgen Inc., and AbbVie Inc., accounted for a ... The prominent players in this market are focusing aggressively ... product portfolio, which is likely to lead to market ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
Breaking Biology Technology: